Industries > Pharmaceutical/Biotech | SupplyChainBrain
Webinars
Podcasts
Videos
Events
Subscribe
Sign In
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Pharmaceutical/Biotech: Page 31
Watch: What to Do About the Vaccine Surplus in the U.S.
Suresh Acharya, Professor of Practice in the Robert H. Smith School of Business at the University of Maryland, addresses the excess of COVID-19 vaccine doses in the U.S., and what to do about it.
Vaccine Shortages Hit Global Supply Program, Halting Rollouts
A string of nations across Africa and Asia have run out of COVID-19 vaccines or are on the brink of doing so, months after receiving first shipments from a global program meant to equitably distribute the lifesaving shots.
AstraZeneca Vaccine Faces More Supply Hurdles, Now From Thailand
AstraZeneca Plc’s COVID-19 vaccine manufacturing partner in Southeast Asia has missed a delivery target in Thailand and shipments to other countries in the region have been delayed, the latest setback for a shot that was meant to be the backbone of the global inoculation effort.
Podcast | What’s Wrong With the Biopharma Supply Chain?
Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect.
One plan, no Excel, real-time decisions with HP Inc.
Anaplan
Disruption has pushed many companies in the direction of using one plan — join our webinar to learn about the HP Inc. digital transformation success story.
Specter of Future Pandemics Spurs Push for Vaccines in 100 Days
COVID-19 has been devastating. A future pandemic could be far worse.
Problems at Biggest Vaccine Maker Leave World Short on Covid Shots
Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled COVID-19 vaccination programs as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.
Watch: Tracking the COVID-19 Crisis in India
Bert Burger, economist and resident expert on India with Atradius, details the state of that country’s struggle to contain the COVID-19 virus.
Biden’s Supply Chain Plan Aims to Boost Medicine, Chip Output
President Biden released a multi-pronged strategy to secure critical supply chains in products ranging from medicines to microchips, and is also weighing a potential trade probe that could result in U.S. tariffs on certain magnet imports.
Watch: The State of the Air Forwarding Industry
Brandon Fried, Executive Director of the Airforwarders Association, tells how his industry has weathered the COVID-19 pandemic so far, and what changes might be in the offing when it’s over.
Watch: Can We Build a Domestic Supply Chain for PPE?
Kezia Fitzgerald, co-founder of CareAline, tells how her company responded to a need for isolation gowns during the COVID-19 pandemic, and describes what it will take to set up a domestic supply of personal protective equipment (PPE) for the future.
World’s Supply of Chips Is in Danger Unless Taiwan Gets Vaccines
Having successfully sidestepped the first Covid wave, the government now faces a health emergency — only about 1% of its population is vaccinated so far — with the potential to disrupt the chip industry that dominates the local economy, and which is critical to an already-squeezed global supply.
Previous Page
Page 31 of 336
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site